News from the debiopharm group A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 07, 2013, 03:00 ET

Experimental Therapeutics Centre and Debiopharm Group™ to Collaborate for the Development of an Epigenetic Innovative Oncology Target

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and...

Oct 04, 2013, 04:00 ET

Presented by the Japanese Cancer Association and Debiopharm Group™ The 'JCA Mauvernay Award 2013' goes to Doctors Kitabayashi and Yano

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that...

Sep 09, 2013, 09:35 ET

Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm

Debiopharm Group (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target...

Sep 05, 2013, 03:00 ET

Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast

Go To Market Consulting Inc. (Go To Market), a San Francisco headquartered business development representation and marketing services life...

Sep 02, 2013, 03:00 ET

Debiopharm Group™ Initiates Phase I Dose Escalation Study With Debio 1347 (CH5183284) in Advanced Solid Tumors with FGFR Alterations

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that...

Aug 29, 2013, 03:00 ET

Debiopharm Group™ Presents the 'Debiopharm Group Life Sciences Award 2013' and two 'Junior Debiopharm Group Life Sciences Awards 2013' During the Annual EPFL SV- Life Science Symposium

Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs...

Jul 04, 2013, 03:00 ET

Quartz Bio SA Supports Debiopharm Group Precision Medicine Bioinformatics

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...

Jun 19, 2013, 03:46 ET

Aurigene and Debiopharm Group™ Report Nomination of Development Candidate Debio 0617B in Oncology

Aurigene Discovery Technologies, a Bangalore-based biotech focusing on small molecule and peptide drug discovery and Debiopharm Group™...

Jun 07, 2013, 03:00 ET

Diagnoplex S.A. Closes a Financing Round led by Debiopharm Group™

Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global...

Jun 04, 2013, 04:00 ET

Debiopharm Group™ Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies for Patients With Selected Solid Malignancies

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of...

May 23, 2013, 03:00 ET

Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven...

Apr 24, 2013, 03:00 ET

Oncotest GmbH and Debiopharm Group Announce a Successful Partnership in the Identification of Biomarker Candidates

Oncotest GmbH and Debiopharm Group™ (Debiopharm) a Swiss-based global biopharmaceutical group, are pleased to announce the successful...

Apr 18, 2013, 03:00 ET

Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients

Suzhou Ascepion Pharmaceuticals, Inc. (Ascepion), a Chinese leading biotech company focusing on the discovery and development of world-class...

Apr 10, 2013, 02:00 ET

Shasun Pharmaceuticals Ltd and Debiopharm Group™ enter into licensing agreement for the manufacturing and commercialization of Huperzine-A

 Shasun Pharmaceuticals Ltd, a global pharmaceutical contracting organization offering world class capabilities and facilities to provide...

Jan 09, 2013, 04:00 ET

Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group

Debiopharm Group™ (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a...

Jan 08, 2013, 01:00 ET

Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347)

Chugai Pharmaceutical Co., Ltd. ("Chugai") and Debiopharm GroupTM ("Debiopharm") announced today that on December 17, 2012, they entered into a...

Dec 07, 2012, 03:00 ET

Dr. Reddy's Launches Debiopharm's Pamorelin® LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...

Sep 21, 2012, 03:00 ET

The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 'JCA-Mauvernay Award' for their Innovative and Outstanding Cancer Research

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...

Aug 27, 2012, 03:00 ET

Debiopharm Announces First Patient Enrolled in Phase III Study for the Rare Disease Central Precocious Puberty

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...

Jul 24, 2012, 03:00 ET

Debiopharm Group™ - First Patient Treated in Phase III Study With Subcutaneous Administration of Debio 8206 for Treatment of Advanced Prostate Cancer

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription...